Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Italian-based Stevanato Group has signed an agreement with Colanar, a provider of small-batch pharma filling machines.
read more
PsyBio Therapeutics has initiated process development of its proprietary biosynthetic formulation of norbaeocystin in collaboration with the Advanced Biofuels and Bioproducts Process Development Unit.
read more
Wednesday, January 25, 2017
Margo Holland has been named as the Vice President of Global Quality at Worldwide Clinical Trials.
read more
RxE2 and Thrifty White Pharmacy have announced a new E2 Dispensing service within the United States.
read more
Lonza announced new investments in GMP laboratories and mid-scale manufacturing assets at its API manufacturing center in Nansha, China. The investments, totaling over $22 million, will allow Lonza to provide a smoother transition from small-scale to...
read more
Shanghai Henlius Biotech, Inc. and Organon announced that the European Medicines Agency (EMA) has validated the marketing authorization application (MAA) for HLX11, an investigational biosimilar of Perjeta® (pertuzumab). Pertuzumab has been approved ...
read more
The NIIMBL announces that they have received $8.9 million from the U.S. Department of Commerce's NIST.
read more
Thursday, January 21, 2016
Biovest International Inc. announced that it will spin off its instrument and contract manufacturing offerings into a single wholly-owned subsidiary named “Cell Culture Company, LLC.” Cell Culture Company will supply automated single-use perfusion ...
read more
Thursday, February 11, 2016
Lonza Houston, Inc., a viral gene therapy manufacturing company, and Renova™ Therapeutics, a biopharmaceutical company developing gene therapy treatments for congestive heart failure and other chronic diseases, have entered into a Manufacturing ...
read more
Permira, a global private equity firm, has announced that a company backed by the Permira funds has signed a definitive agreement to acquire Lyophilization Services of New England, Inc (“LSNE”), a contract development and manufacturing organization ...
read more
Thursday, February 08, 2018
Two Labs announced it has acquired MKO Global Partners, a strategic global life sciences consulting firm focused on payer strategy, market access, and pricing in the pharmaceutical and biotech markets.
read more
Thursday, October 20, 2022
Ardena, a fully integrated Contract Development and Manufacturing Organization (CDMO) assisting biopharma companies with services spanning across the development life cycle, is investing into almost trebling the size of its Swedish facility as part ...
read more
Chrysalis, a GMP-ready space and service provider, has launched following the acquisition of facility assets from Azzur Group and a strategic ownership investment to fuel future growth and expansion.
read more
Wednesday, October 30, 2019
Cyclo Therapeutics has signed an agreement with Worldwide Clinical Trials, a CRO, to conduct a clinical trial to evaluate safety and efficacy in Alzheimer’s Disease.
read more
Symbiosis has signed a supply agreement with AstraZeneca for sterile manufacture of the COVID-19 recombinant adenovirus vaccine known as AZD1222.
read more